HSD17B4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.530400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.723400E-01
Normal-vs-Stage2
6.344000E-01
Normal-vs-Stage3
7.411800E-02
Normal-vs-Stage4
6.708200E-01
Stage1-vs-Stage2
5.575200E-01
Stage1-vs-Stage3
2.060800E-01
Stage1-vs-Stage4
6.364200E-01
Stage2-vs-Stage3
1.709790E-01
Stage2-vs-Stage4
1.979780E-01
Stage3-vs-Stage4
9.850400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.454800E-01
Normal-vs-AfricanAmerican
9.537600E-01
Normal-vs-Asian
3.778400E-01
Caucasian-vs-AfricanAmerican
4.574400E-01
Caucasian-vs-Asian
2.119800E-01
AfricanAmerican-vs-Asian
2.472800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.021600E-01
Normal-vs-Female
7.258400E-01
Male-vs-Female
4.773800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.441800E-01
Normal-vs-Age(41-60Yrs)
9.311600E-01
Normal-vs-Age(61-80Yrs)
5.316400E-01
Normal-vs-Age(81-100Yrs)
6.874600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.600000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.375200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.575800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.859600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.857200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.754800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.882600E-01
Normal-vs-Daily Drinker
3.152200E-01
Normal-vs-Weekly Drinker
4.070800E-01
Normal-vs-Occasional Drinker
9.480600E-01
Normal-vs-Social Drinker
5.238600E-01
Non Drinker-vs-Daily Drinker
3.991600E-01
Non Drinker-vs-Weekly Drinker
5.786400E-01
Non Drinker-vs-Occasional Drinker
1.725810E-01
Non Drinker-vs-Social Drinker
7.931600E-01
Daily Drinker-vs-Weekly Drinker
8.838400E-01
Daily Drinker-vs-Occasional Drinker
6.602000E-02
Daily Drinker-vs-Social Drinker
3.282600E-01
Weekly Drinker-vs-Occasional Drinker
1.504440E-01
Weekly Drinker-vs-Social Drinker
4.750800E-01
Occasional Drinker-vs-Social Drinker
3.289000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.696390E-01
Normal-vs-Grade 2
6.585600E-02
Normal-vs-Grade 3
4.716100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.059600E-01
Grade 1-vs-Grade 3
5.123400E-01
Grade 1-vs-Grade 4
1.696390E-01
Grade 2-vs-Grade 3
8.615600E-01
Grade 2-vs-Grade 4
6.585600E-02
Grade 3-vs-Grade 4
4.716100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.653400E-01
Normal-vs-NonDiabetic
5.608600E-01
Diabetic-vs-NonDiabetic
8.631600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.124600E-01
Normal-vs-NoPancreatitis
6.039600E-01
Pancreatitis-vs-NoPancreatitis
6.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.121000E-01
Normal-vs-N1
6.532400E-01
N0-vs-N1
9.799800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.996600E-01
Normal-vs-TP53-NonMutant
7.772800E-01
TP53-Mutant-vs-TP53-NonMutant
7.927000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
